Skip to content
Back to announcement

20240912_SCPI_Tanggapan atas Permintaan Penjelasan Bursa_31725589_lamp1.pdf

Other Text extracted SCPI

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
                                                                               Sinarmas MSIG Tower 37th floor unit 102-106
                                                                                                 Jl. Jend. Sudirman Kav 21
                                                                                         Karet, Setiabudi, Jakarta Selatan,
                                                                                                         DKI Jakarta 12920
                                                                                              Phone No (62) 21-31107000
                                                                                                 Fax No (62) 21-31107009



No. 092/OPI/IX/2024                                               Jakarta, 5 September 2024

Kepada Yth./ To:
Bursa Efek Indonesia / Indonesia Stock Exchange (“BEI”)

Indonesia Stock Exchange Building,
Tower I, 6th Floor,
Jl. Jend. Sudirman Kav.52-53, Jakarta 12190 – Indonesia

U.p./Attn:       Kepala Divisi Penilaian Perusahaan 3 / Head of Company Assessment Division 3


Perihal: Penyampaian Tanggapan atas Surat         Subject: Response Submission to BEI’s Letter
BEI     sehubungan    dengan    Permintaan        concerning Request for Explanation of PT
Penjelasan PT Organon Pharma Indonesia Tbk        Organon Pharma Indonesia Tbk


Dengan hormat,                                    Dear Madam,

Merujuk surat BEI No. S-09297/BEI.PP3/09-2024     Referring to BEI’s letter No. S-09297/BEI.PP3/09-
tanggal 3 September 2024 tentang Permintaan       2024 dated 3 September 2024 regarding Request
Penjelasan PT Organon Pharma Indonesia Tbk        for Explanation of PT Organon Pharma Indonesia
(“Surat BEI”) yang ditujukan kepada PT Organon    Tbk (“BEI’s Letter”) addressed to PT Organon
Pharma Indonesia Tbk (“Perseroan”), bersama       Pharma Indonesia Tbk (“Company”), with this
dengan surat ini Perseroan bermaksud untuk        letter the Company intends to submit the
memberikan beberapa tanggapan atas Surat BEI      explanation to the pertaining BEI’s letter.
tersebut.


Adapun yang dapat kami berikan klarifikasi saat   At this point of time, Company will give clarification
ini ;                                             for ;
1. Perkembangan proses Voluntary Delisting dan    1. Update on the Voluntary Delisting or Go Private
   Go Private Perseroan
        a. Saat ini jumlah pemegang saham            a. As of now, the number of Company’s
           belum memenuhi minimal kuota                 shareholders has not yet met the required
           ambang batas yang dipersyaratkan             threshold to proceed with the application for
           untuk    melanjutkan      permohonan         the withdrawal of the effective letter from
           pencabutan surat efektif dari OJK.           OJK. Therefore, Company is currently
           Perseroan     sedang      merumuskan         working     on    formulating    alternative
           pendekatan alternatif untuk memenuhi         approaches to meet the applicable
           persyaratan yang berlaku.                    requirements.




Demikian tanggapan yang dapat kami sampaikan. Thus we convey this clarification. Thank you for
Atas perhatiannya, kami mengucapkan terima    your kind attention.
kasih.
Page 2
                                    Sinarmas MSIG Tower 37th floor unit 102-106
                                                      Jl. Jend. Sudirman Kav 21
                                              Karet, Setiabudi, Jakarta Selatan,
                                                              DKI Jakarta 12920
                                                   Phone No (62) 21-31107000
                                                      Fax No (62) 21-31107009




Hormat Kami/Best Regards

PT Organon Pharma Indonesia Tbk




Nama/Name: Daniel
Jabatan/Title: President Director

File

File Open PDF
Source IDX
Size0.42 MB
Published12 Sep 2024
Pages2
Characters3,921
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 7 people and organisations named in the text · linked when the evidence is strong

linked org Jakarta Selatan, DKI Jakarta p.1 ×2
linked org Organon Pharma Indonesia Tbk p.1 ×15
possible org Bursa Efek Indonesia p.1
possible org PT Organon p.1
unresolved org Indonesia Stock Exchange p.1 ×2
unresolved org Pharma Indonesia Tbk p.1
unresolved person Nama/Name: Daniel · Jabatan/Title: President Director p.2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result